Royal Fund Management’s CVS Health CVS Stock Holding History

Royal Fund Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$2	–	304
2025 Q4	$2	Hold	1	–	–	﹤0.01%	288
2025 Q3	$835	Sell	1 -999	-100%	-$68.5K	﹤0.01%	270
2025 Q2	$69K	Sell	1,000 -400	-29%	-$26.2K	0.01%	307
2025 Q1	$93.5K	Hold	1,400	–	–	0.01%	302
2024 Q4	$62.8K	Sell	1,400 -6,000	-81%	-$337K	0.01%	272
2024 Q3	$465K	Buy	+7,400	New	+$432K	0.03%	254
2024 Q2	–	Sell	-4,700	Closed	-$375K	–	298
2024 Q1	$375K	Sell	4,700 -600	-11%	-$45.8K	0.04%	253
2023 Q4	$418K	Buy	+5,300	New	+$377K	0.05%	228
2023 Q3	–	Sell	-5,300	Closed	-$366K	–	276
2023 Q2	$366K	Sell	5,300 -400	-7%	-$28.5K	0.05%	223
2023 Q1	$424K	Sell	5,700 -200	-3%	-$16.8K	0.06%	214
2022 Q4	$550K	Buy	+5,900	New	+$569K	0.09%	172
2022 Q2	–	Sell	-6,400	Closed	-$647K	–	204
2022 Q1	$647K	Buy	+6,400	New	+$672K	0.09%	131

Other funds holding CVS

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Royal Fund Management's CVS Position: Q2 2026 in Review

Royal Fund Management reduced its CVS Health (CVS) stake by 15% in Q2 2026, selling an estimated $1.17M and leaving 75,179 shares worth $7.78M. The position accounts for 0.65% of the portfolio, ranked #47.

Royal Fund Management first reported a position in CVS in Q1 2017 and has held it in 37 quarters since. The position peaked at $10.9M in Q3 2024. 567 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Royal Fund Management held 75,179 shares of CVS Health worth $7.78M as of Q2 2026.
Royal Fund Management sold 13,122 CVS Health shares in Q2 2026, an estimated $1.17M.
CVS Health made up 0.65% of Royal Fund Management's portfolio in Q2 2026, its #47 holding.
Royal Fund Management first reported a position in CVS Health in Q1 2017 and has held it in 37 quarters since.
Royal Fund Management's CVS Health position peaked at $10.9M in Q3 2024.
567 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.